Trials / Completed
CompletedNCT01015092
Cardiovascular Risk Evaluation and Antiretrovirals in HIV
Predicted 10-year Coronary Heart Disease Risk in HIV and Implications for Clinical Management: the CREATE Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,024 (actual)
- Sponsor
- King's College London · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine the main factors contributing to predicted 10 year cardiovascular risk in an HIV infected cohort, and the role of anti-HIV drug use in altering this risk
Conditions
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2006-09-01
- Completion
- 2006-11-01
- First posted
- 2009-11-17
- Last updated
- 2009-11-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01015092. Inclusion in this directory is not an endorsement.